You Searched For "Novartis" and got 18 results
Sort By:
3 mins read
Novartis debuted its first integrated sustainability and finance report this year — more companies are likely to follow suit
The global pharmaceutical company, Novartis, released its first-ever integrated social impact repor…
Julia Hood
2 mins read
Novartis Is A Classic Case Of A Company Where Executive Compensation Is Misaligned With Shareholders' Interests
In our view, Novartis has had a history of sub-par disclosure and remuneration practices even befor…
GMI Ratings
2 mins read
'These are extraordinarily serious allegations': Pharma giant Novartis faces questions over payments to a Michael Cohen-linked organization
Novartis was contacted in November 2017 by lawyers from the Special Counsel's office regarding the …
Lydia Ramsey
3 mins read
A new Senate report says that Novartis had more contact with Michael Cohen than it let on
"We disagree with the report's conclusion that we issued a misleading public statement regarding th…
Lydia Ramsey
2 mins read
The top lawyer at Novartis is leaving the company after it signed a $1.2 million contract with Michael Cohen's consulting firm, took one meeting, and realized he couldn't help them
"With the recent change in administration, Novartis believed that Michael Cohen could advise the co…
Lydia Ramsey
4 mins read
'We're light years ahead of where we were': Novartis CEO Vas Narasimhan told us how the Swiss drug giant is using AI for everything from evaluating managers to predicting its financials
A long-running effort termed "Data 42" aims to mine Novartis research data for paths to new drugs. …
Emma Court,Matt Turner
1 min read
Novartis CEO said he was 'completely blindsided' by Michael Cohen contract
Novartis changed CEOs in February, with Narasimhan replacing former CEO Joe Jimenez. Narasimhan was…
Lydia Ramsey
2 mins read
Cancer-therapy provider Endocyte spikes 50% after Novartis agrees to buy it for $2.1 billion
"We are thrilled that Novartis recognizes the potential for 177Lu-PSMA-617 to change the treatment …
Ethel Jiang
2 mins read
Novartis is going after a $5 billion market with a new treatment for vision loss. That's a big threat to Regeneron
Age-related macular degeneration is a leading cause of vision loss in the US in people over 50, acc…
Lydia Ramsey
4 mins read
Swiss drug giant Novartis has done $60 billion in deals over the past 18 months. One sentence from its CEO reveals the core strategy.
Most biotech companies don't yet sell a product, so investors instead bet on factors like the promi…
Emma Court,Matt Turner
5 mins read
Novartis, one of the world's largest drugmakers, is turning to AI and data science to reinvent its business - and it's become Microsoft's shining example of 'tech intensity'
Bodson, formerly the chief digital officer of British retailer Sainsburys' Argos and a senior group…
Ashley Stewart
3 mins read
Novartis CEO: Here Are 3 Things Big Pharma Must Do To Survive
His own company just came face to face with one of the industry's big threats, weaker patents and g…
Max Nisen
2 mins read
Drug giant Novartis is going after a $5 billion eye-drug market
In data presented Friday at the American Academy of Opthamology annual conference, Novartis' drug b…
Lydia Ramsey
1 min read
Digital hub ''Novartis Biome India'' launched in Hyderabad
Claimed to be the first in Asia, the 'Novartis BiomeIndia' is aimed at boosting connection and inte…
PTI
4 mins read
Pharma giant Novartis has been on a tear. CEO Vas Narasimhan told us how wearing jeans to work is helping transform the Swiss company.
So far it's working, though it'll ultimately be a five-year journey, Narasimhan told Business Insid…
Emma Court,Matt Turner
4 mins read
Elizabeth Warren and Bernie Sanders just slammed the Swiss drug giant Novartis over a new controversy swirling around the world's most expensive drug
In the pharmaceutical industry, where data is the basis for approvals of life-or-death drugs, data …
Emma Court
6 mins read
Microsoft just forged a key alliance with the Swiss pharma giant Novartis to win a bigger piece of an $11 billion market
The first is using AI for exploration, seeing whether researchers can sift through Novartis' resear…
Lydia Ramsey
3 mins read
The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug
In applying for approval, Novartis submitted manipulated mice testing data to US regulators, the US…